Disc Medicine Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript
All right. Good morning, everyone. Thanks for joining us here at the SVB Securities Global Biopharma Conference. My name is Tom Smith, one of the senior biotech analysts here at SVB, and really excited to be hosting this next fireside chat with Disc Medicine. And from the company, happy to welcome CEO and President, John Quisel. John, thanks for joining us.
Thanks, Tom. Good to see you.
Likewise. Just one quick housekeeping note here for investors joining us on the webcast. Feel free to submit any questions for John into the webcast portal or you can email them to me directly at [email protected].
And with that, John, maybe you could just kick us off here by giving a brief overview of Disc and -- for those in the audience who may be a little less familiar with the story.
Perfect, Tom. Yeah.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |